Den senaste kunskapen om PMS belyses i följande artiklar:

1. Andersch B, Wendestam C, Hahn L, Öhman R.
Premenstrual Compalints. I. Prevalence of Premenstrual Symptoms in a Swedish Urban Population.
J Psychosom Obst Gyn 5: 39-49; 1986.

2. Andréen L, Sundström-Poromaa I, Bixo M, Nyberg S, Bäckström T.
Allopregnanolone concentration and mood - a bimodal association in postmenopausal women treated with oral progesterone.
Psychopharmacology 187:209-221; 2006.

3. Bäckström T.
Premenstrual syndrome, In: Current Therapy in Endocrinology and Metabolism,
Bardin CW (ed.)

BC Decker Inc., Philadelphia, 1991.

4. Bäckström T, Andréen L, Björn I, Johansson IM, Löfgren M.

The role of progesterone and GABA in PMS/PMDD.
Chapter 13 in a Textbook on PMS.

5. Bäckström T, Andréen L, Bixo M, Björn I, Fernández G, Johansson IM, Lundgren P, Löfgren M, Nyberg S,

Ragagnin G, Poromaa-Sundström I, Strömberg J, van Broekhoven F, van Wingen G, Wang, MD.

Neuroactive Steroids in Brain and Relevance to Mood.
Chapter 20 in a Textbook on Psychoneurology.

6. Halbreich U, Bäckström T, Eriksson E, O'Brien S, Calil H, Ceskova E, Dennerstein L, Douki S, Freeman E,

Genazzani A, Heuser I, Kadri N, Rapkin A, Steiner M, Wittchen HU, Yonkers K.

Clinical diagnostic criteria for premenstrual syndrome and guidelines for their quantification for research studies.
Gynecological Endocrinology 23: 123-130; 2007.

7. Matsumoto T, Ushiroyama T, Morimura M, Moritani T, Hayashi T, Suzuki T, Tatsumi N.

Autonomic nervous system activity in the late luteal phase of eumenorrheic women with premenstrual symptomatology.
J Psychosomatic Ob/Gyn 27: 131-139; 2006.

8. Matsumoto T, Ushiroyama T, Tatsumi N.

Lower peripheral circulation in eumenorrheic young women with premenstrual symptoms.
BioPsychoSocial Medicine 1:8; 2007.

9. Matsumoto T, Ushiroyama T, Kimura T, Hayashi T, Moritani T.

Altered autonomic nervous system activity as a potential etiological factor of premenstrual syndrome

and premenstrual dysphoric disorder.
Manuscript 2007.

10. Nyberg S, Bäckström T, Zingmark E, Purdy RH, Sundström-Poromaa I.

Allopregnanolone decrease with symptom improvement during placebo and gonadotropin-releasing

hormone agonist treatment in women with severe premenstrual syndrome.
Gynecological Endocrinology 23: 257-266; 2007.

11. van Wingen GA, van Broekhoven F, Verkes RJ, Petersson KM, Bäckström T, Buitelaar JK, Fernández G.

Progesterone selectively increases amygdala reactivity in women.
Molecular Pcychiatry 1-9; 2007.